{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T01:14:50Z","timestamp":1794618890340,"version":"4.9.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"CAMS Innovation Fund for Medical Sciences","award":["2021-I2M-1-008"],"award-info":[{"award-number":["2021-I2M-1-008"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-026-03104-4","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T01:54:09Z","timestamp":1771898049000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["The cholesterol, high-density lipoprotein, and glucose (CHG) index as a novel metabolic marker for predicting adverse outcomes in myocardial infarction survivors: insights from two large prospective cohorts"],"prefix":"10.1186","volume":"25","author":[{"given":"Yanjun","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen\u2019ge","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jining","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangyu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kefei","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"key":"3104_CR1","doi-asserted-by":"crossref","unstructured":"Collaborators GB of CD and R 2023. Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990\u20132023. J Am Coll Cardiol. 2025","DOI":"10.2139\/ssrn.5392535"},{"issue":"6","key":"3104_CR2","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1093\/eurheartj\/ehac667","volume":"44","author":"DM Christensen","year":"2022","unstructured":"Christensen DM, Schjerning AM, Smedegaard L, Charlot MG, Ravn PB, Ruwald AC, et al. Long-term mortality, cardiovascular events, and bleeding in stable patients 1 year after myocardial infarction: a Danish nationwide study. Eur Heart J. 2022;44(6):488\u201398.","journal-title":"Eur Heart J"},{"issue":"12","key":"3104_CR3","first-page":"723","volume":"14","author":"DM Christensen","year":"2026","unstructured":"Christensen DM, Zahir D, Garred CH, Nouhravesh N, Elmegaard M, Malmborg M, et al. Long-term outcomes of recurrent myocardial infarction: a nationwide Danish study. Eur Heart J Acute Cardiovasc Care. 2026;14(12):723\u201331.","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"1","key":"3104_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02437-2","volume":"23","author":"J Yi","year":"2024","unstructured":"Yi J, Qu C, Li X, Gao H. Insulin resistance assessed by estimated glucose disposal rate and risk of atherosclerotic cardiovascular diseases incidence: the multi-ethnic study of atherosclerosis. Cardiovasc Diabetol. 2024;23(1):349.","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"3104_CR5","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/jdi.14343","volume":"16","author":"A Mansoori","year":"2025","unstructured":"Mansoori A, Nosrati M, Dorchin M, Mohammadyari F, Derakhshan-Nezhad E, Ferns G, et al. A novel index for diagnosis of type 2 diabetes mellitus: cholesterol, high density lipoprotein, and glucose (CHG) index. J Diabetes Investig. 2025;16(2):309\u201314.","journal-title":"J Diabetes Investig"},{"issue":"1","key":"3104_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02906-2","volume":"24","author":"Z Guo","year":"2025","unstructured":"Guo Z, Xiong Z, Zhang W, Chen G, Xie M, Zhou Z, et al. Association between cholesterol, high-density lipoprotein, and glucose index and risks of cardiovascular and all-cause mortality in patients with calcific aortic valve stenosis: the ARISTOTLE cohort study. Cardiovasc Diabetol. 2025;24(1):393.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"3104_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3):e1001779.","journal-title":"PLoS Med"},{"issue":"4","key":"3104_CR8","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/met.2008.0034","volume":"6","author":"LE Simental-Mend\u00eda","year":"2008","unstructured":"Simental-Mend\u00eda LE, Rodr\u00edguez-Mor\u00e1n M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299\u2013304.","journal-title":"Metab Syndr Relat Disord"},{"issue":"4","key":"3104_CR9","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1161\/CIRCULATIONAHA.115.019861","volume":"134","author":"EA Bohula","year":"2016","unstructured":"Bohula EA, Bonaca MP, Braunwald E, Aylward PE, Corbalan R, De Ferrari GM, et al. Atherothrombotic risk stratification and the efficacy and safety of vorapaxar in patients with stable ischemic heart disease and previous myocardial infarction. Circulation. 2016;134(4):304\u201313.","journal-title":"Circulation"},{"issue":"16","key":"3104_CR10","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1161\/CIR.0b013e31826e1058","volume":"126","author":"K Thygesen","year":"2012","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. Circulation. 2012;126(16):2020\u201335.","journal-title":"Circulation"},{"issue":"1","key":"3104_CR11","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.0006-341X.2005.030814.x","volume":"61","author":"PJ Heagerty","year":"2005","unstructured":"Heagerty PJ, Zheng Y. Survival model predictive accuracy and ROC curves. Biometrics. 2005;61(1):92\u2013105.","journal-title":"Biometrics"},{"issue":"8","key":"3104_CR12","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.jclinepi.2014.03.012","volume":"67","author":"ME Glickman","year":"2014","unstructured":"Glickman ME, Rao SR, Schultz MR. False discovery rate control is a recommended alternative to Bonferroni-type adjustments in health studies. J Clin Epidemiol. 2014;67(8):850\u20137.","journal-title":"J Clin Epidemiol"},{"issue":"24","key":"3104_CR13","doi-asserted-by":"publisher","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","volume":"73","author":"SM Grundy","year":"2019","unstructured":"Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of blood cholesterol: a report of the American college of cardiology\/american heart association task force on clinical practice guidelines. J Am Coll Cardiol. 2019;73(24):e285-350.","journal-title":"J Am Coll Cardiol"},{"key":"3104_CR14","unstructured":"WHO Consultation on Obesity (1999: Geneva S, Organization WH. Obesity\u202f: preventing and managing the global epidemic\u202f: report of a WHO consultation [Internet]. World Health Organization; 2000."},{"issue":"1","key":"3104_CR15","first-page":"83","volume":"15","author":"BF Zhou","year":"2002","unstructured":"Zhou BF. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults--study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci BES. 2002;15(1):83\u201396.","journal-title":"Biomed Environ Sci BES"},{"issue":"6","key":"3104_CR16","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S2213-8587(21)00045-0","volume":"9","author":"XF Pan","year":"2021","unstructured":"Pan XF, Wang L, Pan A. Epidemiology and determinants of obesity in China. Lancet Diabetes Endocrinol. 2021;9(6):373\u201392.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"3104_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02413-w","volume":"23","author":"N Kaynak","year":"2024","unstructured":"Kaynak N, Kennel V, Rackoll T, Schulze D, Endres M, Nave AH. Impaired glucose metabolism and the risk of vascular events and mortality after ischemic stroke: a systematic review and meta-analysis. Cardiovasc Diabetol. 2024;23(1):323.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3104_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02276-1","volume":"23","author":"Q Chen","year":"2024","unstructured":"Chen Q, Xiong S, Ye T, Gao Y, Wang J, Li X, et al. Insulin resistance, coronary artery lesion complexity and adverse cardiovascular outcomes in patients with acute coronary syndrome. Cardiovasc Diabetol. 2024;23(1):172.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3104_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02807-4","volume":"24","author":"E Xie","year":"2025","unstructured":"Xie E, Cai H, Ye Z, Yang M, Feng L, Zhu C, et al. Association of prediabetes and insulin resistance on prognosis of patients with moderate-to-severe coronary artery calcification: a prospective cohort study. Cardiovasc Diabetol. 2025;24(1):262.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3104_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-13032-0","volume":"15","author":"N Mesri Alamdari","year":"2025","unstructured":"Mesri Alamdari N, Lotfi Yagin N, Ghaffari S, Roshanravan N, Zarrintan A, Mobbaseri M. The different effects of admission blood glucose levels on the outcomes of ST elevation myocardial infarction patients with and without diabetes. Sci Rep. 2025;15(1):27682.","journal-title":"Sci Rep"},{"issue":"1","key":"3104_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02648-1","volume":"24","author":"A Rossi","year":"2025","unstructured":"Rossi A, Masi D, Zilich R, Baccetti F, Baronti W, Falcetta P, et al. Lipid-lowering therapy and LDL target attainment in type 2 diabetes: trends from the Italian Associations of Medical Diabetologists database. Cardiovasc Diabetol. 2025;24(1):94.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3104_CR22","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12933-023-01936-y","volume":"22","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Chen S, Tian X, Wang P, Xu Q, Xia X, et al. Association between cumulative atherogenic index of plasma exposure and risk of myocardial infarction in the general population. Cardiovasc Diabetol. 2023;22(1):210.","journal-title":"Cardiovasc Diabetol"},{"key":"3104_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1323615","volume":"14","author":"H Zhao","year":"2024","unstructured":"Zhao H, Wang Y, Wang C, Meng Q. Association between triglyceride glucose index and adverse clinical outcomes in patients with acute myocardial infarction and LDL-C\u22641.8 mmol\/L who underwent percutaneous coronary intervention: a prospective cohort study. Front Endocrinol. 2024;14:1323615.","journal-title":"Front Endocrinol"},{"issue":"1","key":"3104_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-025-01933-z","volume":"17","author":"H Zhou","year":"2025","unstructured":"Zhou H, Shi Y, Zhou X. Comparison of nine insulin resistance surrogates for predicting cardiovascular disease: a cohort study. Diabetol Metab Syndr. 2025;17(1):365.","journal-title":"Diabetol Metab Syndr"},{"issue":"13","key":"3104_CR25","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.033997","volume":"13","author":"S Pang","year":"2024","unstructured":"Pang S, Wang Y, Sun S, Wang S, Li F, Zhao W, et al. Associations between life\u2019s essential 8 and insulin resistance among nondiabetic adults. J Am Heart Assoc. 2024;13(13):e033997.","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"3104_CR26","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.028985","volume":"12","author":"Z Ke","year":"2023","unstructured":"Ke Z, Huang R, Xu X, Liu W, Wang S, Zhang X, et al. Long-term high level of insulin resistance is associated with an increased prevalence of coronary artery calcification: the CARDIA study. J Am Heart Assoc. 2023;12(11):e028985.","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"3104_CR27","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.2337\/dc24-0475","volume":"47","author":"R Sun","year":"2024","unstructured":"Sun R, Wang J, Li M, Li J, Pan Y, Liu B, et al. Association of insulin resistance with cardiovascular disease and all-cause mortality in type 1 diabetes: systematic review and meta-analysis. Diabetes Care. 2024;47(12):2266\u201374.","journal-title":"Diabetes Care"},{"issue":"1","key":"3104_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-02073-2","volume":"22","author":"X Tian","year":"2023","unstructured":"Tian X, Chen S, Xu Q, Xia X, Zhang Y, Wang P, et al. Magnitude and time course of insulin resistance accumulation with the risk of cardiovascular disease: an 11-years cohort study. Cardiovasc Diabetol. 2023;22(1):339.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3104_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02651-6","volume":"24","author":"Y Feng","year":"2025","unstructured":"Feng Y, Yin L, Huang H, Hu Y, Lin S. Assessing the impact of insulin resistance trajectories on cardiovascular disease risk using longitudinal targeted maximum likelihood estimation. Cardiovasc Diabetol. 2025;24(1):112.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3104_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02675-y","volume":"24","author":"D Mo","year":"2025","unstructured":"Mo D, Zhang P, Zhang M, Dai H, Guan J. Cholesterol, high-density lipoprotein, and glucose index versus triglyceride\u2013glucose index in predicting cardiovascular disease risk: a cohort study. Cardiovasc Diabetol. 2025;24(1):116.","journal-title":"Cardiovasc Diabetol"},{"key":"3104_CR31","doi-asserted-by":"publisher","first-page":"1664891","DOI":"10.3389\/fneur.2025.1664891","volume":"16","author":"H Luwen","year":"2025","unstructured":"Luwen H, Linlin L, Ming Y, Lei X. A comparative analysis of the cholesterol\u2013high-density lipoprotein\u2013glucose index and the triglyceride\u2013glucose index in predicting in-hospital mortality in critically ill ischemic stroke patients. Front Neurol. 2025;16:1664891.","journal-title":"Front Neurol"},{"issue":"1","key":"3104_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-018-0762-4","volume":"17","author":"V Ormazabal","year":"2018","unstructured":"Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zu\u00f1iga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17(1):122.","journal-title":"Cardiovasc Diabetol"},{"issue":"23","key":"3104_CR33","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1093\/eurheartj\/ehr236","volume":"32","author":"CW Hamm","year":"2011","unstructured":"Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2011;32(23):2999\u20133054.","journal-title":"Eur Heart J"},{"issue":"7","key":"3104_CR34","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1001\/jama.284.7.835","volume":"284","author":"EM Antman","year":"2000","unstructured":"Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, et al. The TIMI risk score for unstable angina\/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA. 2000;284(7):835\u201342.","journal-title":"JAMA"},{"issue":"14","key":"3104_CR35","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.029670","volume":"12","author":"C Wu","year":"2023","unstructured":"Wu C, Gao X, Li L, Jing Q, Li W, Xu H, et al. Role of ST-segment resolution alone and in combination with TIMI flow after primary percutaneous coronary intervention for ST-segment-elevation myocardial infarction. J Am Heart Assoc. 2023;12(14):e029670.","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"3104_CR36","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1631\/jzus.B1700413","volume":"19","author":"QH Sheng","year":"2018","unstructured":"Sheng QH, Hsu CC, Li JP, Hong T, Huo Y. Combining fragmented QRS and TIMI score for predicting in-hospital short-term prognosis after acute myocardial infarction. J Zhejiang Univ Sci B. 2018;19(5):349\u201353.","journal-title":"J Zhejiang Univ Sci B"},{"issue":"1","key":"3104_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-020-1500-9","volume":"20","author":"A Anand","year":"2020","unstructured":"Anand A, Cudmore S, Robertson S, Stephen J, Haga K, Weir CJ, et al. Frailty assessment and risk prediction by GRACE score in older patients with acute myocardial infarction. BMC Geriatr. 2020;20(1):102.","journal-title":"BMC Geriatr"},{"issue":"3","key":"3104_CR38","doi-asserted-by":"publisher","first-page":"577","DOI":"10.2337\/dc17-1736","volume":"41","author":"BA Bergmark","year":"2018","unstructured":"Bergmark BA, Bhatt DL, Braunwald E, Morrow DA, Steg PG, Gurmu Y, et al. Risk Assessment in Patients with diabetes with the TIMI risk score for atherothrombotic disease. Diabetes Care. 2018;41(3):577\u201385.","journal-title":"Diabetes Care"},{"issue":"8","key":"3104_CR39","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.jacc.2016.11.070","volume":"69","author":"EA Bohula","year":"2017","unstructured":"Bohula EA, Morrow DA, Giugliano RP, Blazing MA, He P, Park JG, et al. Atherothrombotic risk stratification and ezetimibe for secondary prevention. J Am Coll Cardiol. 2017;69(8):911\u201321.","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"3104_CR40","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1161\/CIRCULATIONAHA.117.030950","volume":"137","author":"RP Giugliano","year":"2018","unstructured":"Giugliano RP, Cannon CP, Blazing MA, Nicolau JC, Corbal\u00e1n R, \u0160pinar J, et al. Benefit of Adding ezetimibe to statin therapy on cardiovascular outcomes and safety in patients with versus without diabetes mellitus: results from improve-it (Improved reduction of outcomes: vytorin efficacy international trial). Circulation. 2018;137(15):1571\u201382.","journal-title":"Circulation"},{"issue":"1","key":"3104_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02890-7","volume":"24","author":"S Xu","year":"2025","unstructured":"Xu S, Zhang Z, Li J, Ding Y, Chen Y, Zhou Y, et al. Does diabetes status modify the association between the triglyceride-glucose index and major adverse cardiovascular events in patients with coronary heart disease? A systematic review and meta-analysis of longitudinal cohort studies. Cardiovasc Diabetol. 2025;24(1):317.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3104_CR42","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12933-021-01236-3","volume":"20","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Ding X, Hua B, Liu Q, Gao H, Chen H, et al. Predictive effect of triglyceride-glucose index on clinical events in patients with type 2 diabetes mellitus and acute myocardial infarction: results from an observational cohort study in China. Cardiovasc Diabetol. 2021;20(1):43.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3104_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02209-y","volume":"23","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Gu Y, Zhang B. Associations of triglyceride-glucose (TyG) index with chest pain incidence and mortality among the U.S. population. Cardiovasc Diabetol. 2024;23(1):111.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3104_CR44","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s12933-023-02029-6","volume":"22","author":"S Dong","year":"2023","unstructured":"Dong S, Zhao Z, Huang X, Ma M, Yang Z, Fan C, et al. Triglyceride-glucose index is associated with poor prognosis in acute coronary syndrome patients with prior coronary artery bypass grafting undergoing percutaneous coronary intervention. Cardiovasc Diabetol. 2023;22(1):286.","journal-title":"Cardiovasc Diabetol"},{"key":"3104_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2025.100996","volume":"22","author":"I Dakota","year":"2025","unstructured":"Dakota I, Huang W, Wijayanto MA, Nurhafizah A, Khairunnisa AR, Rachmayanti S, et al. Prognostic value of triglyceride-glucose index on predicting major adverse cardiovascular events in hypertensive patients: a systematic review and meta-analysis. Am J Prev Cardiol. 2025;22:100996.","journal-title":"Am J Prev Cardiol"},{"issue":"1","key":"3104_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01400-z","volume":"8","author":"Y Li","year":"2023","unstructured":"Li Y, Liu Y, Liu S, Gao M, Wang W, Chen K, et al. Diabetic vascular diseases: molecular mechanisms and therapeutic strategies. Signal Transduct Target Ther. 2023;8(1):152.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"3104_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26062574","volume":"26","author":"B Ahn","year":"2025","unstructured":"Ahn B. Advances in insulin resistance-molecular mechanisms, therapeutic targets, and future directions. Int J Mol Sci. 2025;26(6):2574.","journal-title":"Int J Mol Sci"},{"key":"3104_CR48","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8609213","volume":"2020","author":"H Yaribeygi","year":"2020","unstructured":"Yaribeygi H, Sathyapalan T, Atkin SL, Sahebkar A. Molecular mechanisms linking oxidative stress and diabetes mellitus. Oxid Med Cell Longev. 2020;2020:8609213.","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"3104_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01073-0","volume":"7","author":"M Li","year":"2022","unstructured":"Li M, Chi X, Wang Y, Setrerrahmane S, Xie W, Xu H. Trends in insulin resistance: insights into mechanisms and therapeutic strategy. Signal Transduct Target Ther. 2022;7(1):216.","journal-title":"Signal Transduct Target Ther"},{"issue":"7181","key":"3104_CR50","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/nature06796","volume":"451","author":"DJ Rader","year":"2008","unstructured":"Rader DJ, Daugherty A. Translating molecular discoveries into new therapies for atherosclerosis. Nature. 2008;451(7181):904\u201313.","journal-title":"Nature"},{"issue":"4","key":"3104_CR51","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jacc.2012.08.1026","volume":"61","author":"A Varbo","year":"2013","unstructured":"Varbo A, Benn M, Tybj\u00e6rg-Hansen A, J\u00f8rgensen AB, Frikke-Schmidt R, Nordestgaard BG. Remnant cholesterol as a causal risk factor for ischemic heart disease. J Am Coll Cardiol. 2013;61(4):427\u201336.","journal-title":"J Am Coll Cardiol"},{"issue":"32","key":"3104_CR52","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","volume":"38","author":"BA Ference","year":"2017","unstructured":"Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38(32):2459\u201372.","journal-title":"Eur Heart J"},{"issue":"1","key":"3104_CR53","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41421-025-00787-z","volume":"11","author":"Y Cheng","year":"2025","unstructured":"Cheng Y, Shao S, Wang Z, Guan Q, Li H, Liu G, et al. From lipotoxicity to pan-lipotoxicity. Cell Discov. 2025;11(1):27.","journal-title":"Cell Discov"},{"issue":"3","key":"3104_CR54","doi-asserted-by":"publisher","first-page":"247","DOI":"10.12997\/jla.2025.14.3.247","volume":"14","author":"SH Jo","year":"2025","unstructured":"Jo SH. Triglycerides, triglyceride-rich lipoproteins, and remnant cholesterol in atherosclerotic cardiovascular disease. J Lipid Atheroscler. 2025;14(3):247\u201357.","journal-title":"J Lipid Atheroscler"},{"issue":"11","key":"3104_CR55","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1161\/ATVBAHA.116.308305","volume":"36","author":"A Varbo","year":"2016","unstructured":"Varbo A, Nordestgaard BG. Remnant cholesterol and triglyceride-rich lipoproteins in atherosclerosis progression and cardiovascular disease. Arterioscler Thromb Vasc Biol. 2016;36(11):2133\u20135.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"47","key":"3104_CR56","doi-asserted-by":"publisher","first-page":"4791","DOI":"10.1093\/eurheartj\/ehab551","volume":"42","author":"HN Ginsberg","year":"2021","unstructured":"Ginsberg HN, Packard CJ, Chapman MJ, Bor\u00e9n J, Aguilar-Salinas CA, Averna M, et al. Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society. Eur Heart J. 2021;42(47):4791\u2013806.","journal-title":"Eur Heart J"},{"issue":"2","key":"3104_CR57","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.atherosclerosis.2015.01.039","volume":"239","author":"MR Taskinen","year":"2015","unstructured":"Taskinen MR, Bor\u00e9n J. New insights into the pathophysiology of dyslipidemia in type 2 diabetes. Atherosclerosis. 2015;239(2):483\u201395.","journal-title":"Atherosclerosis"},{"issue":"24","key":"3104_CR58","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","volume":"41","author":"J Bor\u00e9n","year":"2020","unstructured":"Bor\u00e9n J, Chapman MJ, Krauss RM, Packard CJ, Bentzon JF, Binder CJ, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2020;41(24):2313\u201330.","journal-title":"Eur Heart J"},{"issue":"5","key":"3104_CR59","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.rec.2014.09.001","volume":"68","author":"A Regueiro","year":"2015","unstructured":"Regueiro A, Fern\u00e1ndez-Rodr\u00edguez D, Brugaletta S, Mart\u00edn-Yuste V, Masotti M, Freixa X, et al. Sex-related impact on clinical outcome of Everolimus-eluting versus bare-metal stents in ST-segment myocardial infarction. Insights from the EXAMINATION trial. Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition). 2015;68(5):382\u20139.","journal-title":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"},{"issue":"7","key":"3104_CR60","doi-asserted-by":"publisher","first-page":"351","DOI":"10.5694\/mja2.70048","volume":"223","author":"S Kazi","year":"2025","unstructured":"Kazi S, Marschner S, Min H, Quintans D, Chong JJ, Khan E, et al. Sex differences in management and outcomes of people with ST-elevation myocardial infarction, New South Wales, 2011-2020: a retrospective cohort study. Med J Aust. 2025;223(7):351\u20138.","journal-title":"Med J Aust"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03104-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03104-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03104-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T13:09:00Z","timestamp":1773320940000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-026-03104-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3104"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03104-4","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"assertion":[{"value":"9 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"UK Biobank has been approved by the National Research Ethics Committee of the National Health Service (NHS). All participants signed informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"80"}}